A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality ...
Ipsen has taken rights to PPAR agonist elafibranor as a treatment for primary biliary cholangitis – a chronic, autoimmune disease in which bile ducts in the liver are gradually destroyed causing ...
School of Chemical Sciences, University of Chinese Academy of Sciences, Beijing 100049, P. R. China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results